| Literature DB >> 23118716 |
Wen-Li Mei1, Bo Zheng1,2, You-Xing Zhao1, Hui-Ming Zhong2, Xun-Li Wu Chen1, Yan-Bo Zeng1, Wen-Hua Dong1, Jiu-Li Huang1, Peter Proksch3, Hao-Fu Dai1.
Abstract
Four new meroterpenes, guignardones F-I (1-4), together with two known compounds guignardones A (5) and B (6) were isolated from the endophytic fungus A1 of the mangrove plant Scyphiphora hydrophyllacea. Their structures and relative configurations were elucidated by spectroscopic data and single-crystal X-ray crystallography. A possible biogenetic pathway of compounds 1-6 was also proposed. All compounds were evaluated for inhibitory activity against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus.Entities:
Keywords: Guignardia sp.; MRSA; Scyphiphora hydrophyllacea; Staphylococcus aureus; marine endophyte; meroterpenes
Mesh:
Substances:
Year: 2012 PMID: 23118716 PMCID: PMC3475268 DOI: 10.3390/md10091993
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1The structures of compounds 1–6.
13C NMR data (100 MHz, CDCl3) for 1–4.
| position | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 1 | 200.2 s | 198.7 s | 194.9 s | 195.0 s |
| 2 | 114.7 s | 105.0 s | 105.8 s | 105.5 s |
| 3 | 173.9 s | 167.1 s | 167.7 s | 168.5 s |
| 4 | 81.3 d | 66.7 d | 65.7 d | 65.7 d |
| 5 | 42.5 t | 36.9 t | 34.5 t | 34.6 t |
| 6 | 81.8 s | 67.1 d | 79.1 d | 79.0 d |
| 7 | 69.3 t | |||
| 8 | 21.9 t | 16.2 t | 16.1 t | 18.7 t |
| 9 | 46.1 d | 43.3 d | 43.2 d | 41.2 d |
| 10 | 80.5 s | 88.2 s | 87.7 s | 88.9 s |
| 11 | 26.5 q | 23.5 q | 22.3 q | 22.1 q |
| 12 | 39.3 t | 37.7 t | 37.4 t | 38.3 t |
| 13 | 25.9 t | 27.0 t | 26.9 t | 24.5 t |
| 14 | 54.1 d | 48.7 d | 48.9 d | 51.1 d |
| 15 | 86.9 s | 145.4 s | 145.4 s | 72.9 s |
| 16 | 19.2 q | 111.3 t | 111.2 t | 28.6 q |
| 17 | 30.0 q | 19.2 q | 19.2 q | 27.5 q |
| OCH3 | 58.3 q | 58.3 q |
Figure 21H-1H COSY and key HMBC correlations of 1–4.
Chart 1The ORTEP view of compound 1.
Figure 3Selected ROESY correlations of 2–4.
1H NMR data (400 MHz, CDCl3) for 1–4.
| position | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 4 | 4.46, d (5.2) | 4.35, br t (2.8) | 4.24, br s | 4.26, br s |
| 5 | 2.31, m | 2.53, dq (13.4, 5.4) | 2.35, m | 2.38, dt (13.6, 4.2) |
| 1.91, m | 2.01, m | 2.23, m | 2.23, m | |
| 6 | 4.48, dd (11.9, 5.4) | 3.70, dd (6.8, 3.6) | 3.71, dd (7.0, 3.6) | |
| 7 | 3.80, d (8.0) | |||
| 3.45, d (8.0) | ||||
| 8 | 3.03, dd (15.0, 3.2) | 2.32, m | 2.33, d (17.3) | 2.62, d (17.6) |
| 1.92, m | 2.28, m | 2.15, m | 2.26, m | |
| 9 | 1.40, dd (12.0, 3.2) | 1.95, m | 1.94, m | 2.04, m |
| 11 | 1.35, s, 3H | 1.32, s, 3H | 1.33, s, 3H | 1.33, s, 3H |
| 12 | 1.76, m, 2H | 2.10, m; 1.81, m | 2.13, m; 1.79, m | 2.01, m; 1.59, m |
| 13 | 1.95, m; 1.22, m | 1.94, m; 1.57, m | 1.91, m; 1.53, m | 1.79, m; 1.58, m |
| 14 | 2.33, m | 2.27, m | 2.17, m | 1.58, m |
| 16 | 1.17, s, 3H | 4.73, m | 4.72, m | 1.20, s, 3H |
| 4.64, m | 4.62, m | |||
| 17 | 1.45, s, 3H | 1.66, s, 3H | 1.65, s, 3H | 1.18, s, 3H |
| OCH3 | 3.47, s, 3H | 3.47, s, 3H |
Scheme 1Plausible biosynthetic pathway of 1–6.